LENZ Therapeutics, Inc.LENZNASDAQ
Loading
EPS Growth TrendStable
Percentile Rank41
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P41
Within normal range
vs 3Y Ago
-1.3x
Contraction
Streak
1 qtr
Consecutive declineStable
PeriodValue
Q3 2025-11.32%
Q2 20250.00%
Q1 2025-15.22%
Q4 2024-21.05%
Q3 20245.00%
Q2 202488.67%
Q1 2024-27.44%
Q4 2023-0.73%
Q3 202359.68%
Q2 2023-127.33%
Q1 20232.91%
Q4 20221.28%
Q3 20228.48%
Q2 2022-0.88%
Q1 2022-48.68%
Q4 2021-29.55%
Q3 202119.63%
Q2 20217.98%
Q1 202168.93%
Q4 2020-1768.29%
Q3 2020-156.25%
Q2 2020-841.18%
Q1 20200.00%